GPR137-RARRES3 Fusion FISH Probe
The GPR137-RARRES3 Fusion FISH Probe is used to confirm a fusion of the GPR137 and RARRES3 genes. The fusion of the GPR137 and RARRES3 genes has been associated with Uterine Carcinosarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| GPR137-RARRES3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| GPR137-RARRES3-20-AQAQ | 20 (40 μL) | 200 μL |
|
RARRES3 Gene Summary
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator. [provided by RefSeq, Jul 2008]
Gene Name: Retinoic Acid Receptor Responder 3
Chromosome: CHR11: 63304272 -63313930
Locus: 11q12.3
GPR137 Gene Summary
The G Protein-coupled Receptor 137 (GPR137) gene is located on chr11 :64051810-64056972 at 11q13.1.
Gene Name: G Protein-coupled Receptor 137
Chromosome: CHR11: 64051810 -64056972
Locus: 11q13.1
Gene Diseases
The GPR137 RARRES3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Carcinosarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|